Delcath Systems DCTH
$18.79 −$0.45 (-2.34%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $18.50 -1.54%
Open$18.89
Prev close$19.24
Day range$18.51 – $19.35
Volume592.1K
Market cap$653.67M
P/E (TTM)117.4
Dividend yield–
DCTH Stock News
Headlines matching Delcath Systems or the DCTH ticker, most recent first.
- H.C. Wainwright Maintains Delcath Systems(DCTH.US) With Buy Rating, Maintains Target Price $32
- H.C. Wainwright Remains a Buy on Delcath Systems (DCTH)
- Craig-Hallum Maintains Delcath Systems(DCTH.US) With Buy Rating, Announces Target Price $24
- BTIG Maintains Buy on Delcath Systems, Raises Price Target to $21 Positive
- H.C. Wainwright Maintains Delcath Systems(DCTH.US) With Buy Rating, Raises Target Price to $32 Positive
- Analysts Are Bullish on Top Healthcare Stocks: Relmada Therapeutics (RLMD), Delcath Systems (DCTH) Positive
- H.C. Wainwright Maintains Delcath Systems(DCTH.US) With Buy Rating, Maintains Target Price $30
- Delcath Systems | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
- Delcath Systems | 8-K: Current report
- CCORF Maintains Delcath Systems(DCTH.US) With Buy Rating, Maintains Target Price $21
- Delcath Systems: Hepzato Demand Momentum Supports Buy Rating and Unchanged $21 Price Target
- BTIG Maintains Delcath Systems(DCTH.US) With Buy Rating, Raises Target Price to $17 Positive
- Analysts Offer Insights on Healthcare Companies: ANI Pharmaceuticals (ANIP), Bristol-Myers Squibb (BMY) and Delcath Systems (DCTH)
- H.C. Wainwright Sticks to Its Buy Rating for Delcath Systems (DCTH)
- Craig-Hallum Maintains Delcath Systems(DCTH.US) With Buy Rating
No comments yet — be the first to weigh in on DCTH.
Sign in to join the discussion.